直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Ad Law Buzz Blog

Natural-ish: A New Decision Underscores NAD’s Expansive Understanding of Natural Claims

January 26, 2024

Authored and Edited by Jennifer E. Fried

“Natural” claims are infamously risky business. Between the specter of class action lawsuits, FTC actions, and competitor challenges, claims that a product is “natural” require special vigilance. A recent NAD case addresses a threshold question that comes up, time and again, in practice: what exactly constitutes a natural claim? 

In the recent Pamprin Botanicals case filed by Bayer Consumer Heaelth (Bayer) against Focus Consumer Healthcare (Focus), NAD considered the challenger’s argument that the claim “naturally good for you ingredients” conveyed a message about the naturalness of Pamprin Botanical’s ingredients. NAD found that it does. It noted that the “naturally good for you ingredients” claim appears alongside a list of the product’s ingredients as well as the visual of a leaf. While NAD found that the claim did not suggest that the “product as a whole” was a natural one, NAD did determine that the “naturally good for you ingredients” claim conveyed that the listed ingredients are, indeed, natural. NAD noted “[t]here is no evidence in the record as to whether the five ingredients listed are indeed natural,” and recommended that the advertiser remove the claim and avoid conveying this message.  

NAD’s finding on this issue is reminiscent of the 2016 Naturally Dry case, where NAD found that the “Naturally Dry” product name conveyed the message that natural ingredients were responsible for the dryness provided by the antiperspirant—a message NAD deemed unsupported.

Key Takeaways

    • Derivations of the word “natural” (e.g. “naturally) can give rise to implied “natural” claims
    • “Natural” claims can be amplified by accompanying imagery (leaves, nature, etc.)
    • The term “botanical” is understood to mean “derived from plants,” as distinct from the “natural” designation


Challenger Bayer also took issue with Focus’s product name--Pamprin Botanicals--on the grounds that this name, too, implied that the product was natural. On this point, NAD sided with the advertiser. Despite the word “Botanical” in the product name, NAD trotted out its familiar standard on name change recommendations: “As a general rule, absent extrinsic evidence that consumers have been confused or misled, NAD will not require an advertiser to change the name of a product simply because a challenger suspects that it may be misleading.”

Here, NAD determined that the name “Pamprin Botanicals” was not expressly false. “Botanical” is defined as “of or relating to plants or botany” or “derived from plants”—a message that was supported in this case. But NAD found that “[n]othing in the plain language of the name conveys the message that all ingredients in Pamprin Botanicals are plant based or that it is an all-natural product.” In reaching its conclusion, NAD distinguished this case from Zarbees Naturals, where NAD found that the product name did, in fact, convey a “natural” message.

Related Practices

Trademark and Brand Management

Advertising

Related Industries

Life Sciences

Pharmaceutical

Related Offices

Washington, DC

Contacts

Jennifer E. Fried
Partner
Washington, DC
+1 202 408 4166
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP